Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada®) in virologically suppressed HIV-infected patients on HAART
Titel:
Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada®) in virologically suppressed HIV-infected patients on HAART
Auteur:
Palacios, R. Hidalgo, C. Ríos, M. J. Rivero, A. Muñoz, L. Lozano, F. Gutiérrez-Ravé, V. Gálvez, M. C. Arco, A. del Santos, J.
Verschenen in:
European journal of clinical microbiology & infectious diseases